152 related articles for article (PubMed ID: 9409310)
1. Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation.
Minamino T; Kitakaze M; Sato H; Asanuma H; Funaya H; Koretsune Y; Hori M
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3191-5. PubMed ID: 9409310
[TBL] [Abstract][Full Text] [Related]
2. Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?
Hatzinikolaou-Kotsakou E; Kartasis Z; Tziakas D; Hotidis A; Stakos D; Tsatalas K; Bourikas G; Kotsakou ME; Hatseras DI
J Thromb Thrombolysis; 2003 Dec; 16(3):155-61. PubMed ID: 15087601
[TBL] [Abstract][Full Text] [Related]
3. Prothrombotic State in Patients With a Left Atrial Appendage Thrombus of Unknown Origin and Cerebrovascular Events.
Meus R; Son M; Sobczyk D; Undas A
Stroke; 2016 Jul; 47(7):1872-8. PubMed ID: 27301942
[TBL] [Abstract][Full Text] [Related]
4. A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation.
Kamath S; Chin BS; Blann AD; Lip GY
Blood Coagul Fibrinolysis; 2002 Oct; 13(7):627-36. PubMed ID: 12439149
[TBL] [Abstract][Full Text] [Related]
5. Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?
Marín F; Roldán V; Climent V; Garcia A; Marco P; Lip GY
Stroke; 2003 May; 34(5):1181-6. PubMed ID: 12663879
[TBL] [Abstract][Full Text] [Related]
6. Platelet nitric oxide metabolites in migraine.
Shimomura T; Murakami F; Kotani K; Ikawa S; Kono S
Cephalalgia; 1999 May; 19(4):218-22. PubMed ID: 10376166
[TBL] [Abstract][Full Text] [Related]
7. Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis.
Li-Saw-Hee FL; Blann AD; Goldsmith I; Lip GY
Am J Cardiol; 1999 Apr; 83(8):1206-9. PubMed ID: 10215285
[TBL] [Abstract][Full Text] [Related]
8. Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation.
Kamath S; Blann AD; Caine GJ; Gurney D; Chin BS; Lip GY
Stroke; 2002 May; 33(5):1237-42. PubMed ID: 11988597
[TBL] [Abstract][Full Text] [Related]
9. Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
Li-Saw-Hee FL; Blann AD; Lip GY
Stroke; 2000 Apr; 31(4):828-33. PubMed ID: 10753983
[TBL] [Abstract][Full Text] [Related]
10. Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation.
Gustafsson C; Blombäck M; Britton M; Hamsten A; Svensson J
Stroke; 1990 Jan; 21(1):47-51. PubMed ID: 2105543
[TBL] [Abstract][Full Text] [Related]
11. Relationship between flow dynamics in the left atrium and hemostatic abnormalities in patients with nonvalvular atrial fibrillation.
Shinohara H; Fukuda N; Soeki T; Takeichi N; Yui Y; Tamura Y; Oki T
Jpn Heart J; 1998 Nov; 39(6):721-30. PubMed ID: 10089934
[TBL] [Abstract][Full Text] [Related]
12. Left atrial appendage function and abnormal hypercoagulability in patients with atrial flutter.
Sakurai K; Hirai T; Nakagawa K; Kameyama T; Nozawa T; Asanoi H; Inoue H
Chest; 2003 Nov; 124(5):1670-4. PubMed ID: 14605033
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: role of nitric oxide.
Minamino T; Kitakaze M; Sanada S; Asanuama H; Kurotobi T; Koretsune Y; Fukunami M; Kuzuya T; Hoki N; Hori M
Circulation; 1998 Oct; 98(17):1721-7. PubMed ID: 9788825
[TBL] [Abstract][Full Text] [Related]
14. Correlation of nitric oxide and atrial natriuretic peptide changes with altered cGMP homeostasis in liver cirrhosis.
Montoliu C; Kosenko E; Del Olmo JA; Serra MA; Rodrigo JM; Felipo V
Liver Int; 2005 Aug; 25(4):787-95. PubMed ID: 15998430
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic exercise and deconditioning on platelet function in women.
Wang JS; Jen CJ; Chen HI
J Appl Physiol (1985); 1997 Dec; 83(6):2080-5. PubMed ID: 9390984
[TBL] [Abstract][Full Text] [Related]
16. Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.
Lip GY; Lowe GD; Rumley A; Dunn FG
Br Heart J; 1995 Jun; 73(6):527-33. PubMed ID: 7626351
[TBL] [Abstract][Full Text] [Related]
17. [Atrial fibrillation. Epidemiology and physiopathology].
Iuliano L; Micheletta F
Haematologica; 2001 Sep; 86(9 Suppl):1-4. PubMed ID: 11759617
[No Abstract] [Full Text] [Related]
18. Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study.
Feinberg WM; Pearce LA; Hart RG; Cushman M; Cornell ES; Lip GY; Bovill EG
Stroke; 1999 Dec; 30(12):2547-53. PubMed ID: 10582976
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis.
Lip GY; Lowe GD; Rumley A; Dunn FG
Am Heart J; 1996 Apr; 131(4):724-30. PubMed ID: 8721646
[TBL] [Abstract][Full Text] [Related]
20. Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation.
Mondillo S; Sabatini L; Agricola E; Ammaturo T; Guerrini F; Barbati R; Pastore M; Fineschi D; Nami R
Int J Cardiol; 2000 Sep; 75(2-3):227-32. PubMed ID: 11077138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
